Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05247788 · ClinicalTrials.gov registry record · NA
Impaired Risk Awareness During Intoxication in DUI Offenders
A NA study of Alcohol Use, sponsored by Mark Fillmore.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 1
- Study location
NCT05247788: Completed NA study of Alcohol Use, sponsored by Mark Fillmore.
NCT05247788 is a NA study of Alcohol Use that has completed, run by Mark Fillmore. The registered enrollment target is 112 participants, below the 266-participant average among 23 other Alcohol Use trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05247788, a NA study of Alcohol Use, has completed, sponsored by Mark Fillmore.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to test the efficacy of experiential-based training to increase DUI offenders' perceptions or risk associated with alcohol use.
Primary Outcome
Alcohol consumption will be assessed at monthly intervals from baseline to follow up and will be measured using a timeline follow back assessment. Participants will self-report data on number of days when the participant demonstrates binge drinking (5+ drinks per day for men; 4+ drinks per day for women).
Conditions Studied
Interventions
- BEHAVIORAL Blood alcohol concentration (BAC) discrimination training
- BEHAVIORAL Performance feedback training
- BEHAVIORAL Blood alcohol concentration (BAC) discrimination training for controls
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2022-02-02 |
| Est. Completion | 2025-03-01 |
| Phase | NA |
What the finished NCT05247788 record still lists
NCT05247788 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 266-participant average among 23 other Alcohol Use trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Alcohol Use appearing as the primary indexed condition, and to 3 interventions - of which Blood alcohol concentration (BAC) discrimination training is the first listed.
NCT05247788 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05247788 about?
NCT05247788 is a clinical study titled "Impaired Risk Awareness During Intoxication in DUI Offenders". This study aims to test the efficacy of experiential-based training to increase DUI offenders' perceptions or risk associated with alcohol use.
What is the current status of trial NCT05247788?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2022-02-02. Estimated completion is 2025-03-01.
What conditions does trial NCT05247788 study?
This clinical trial studies the following conditions: Alcohol Use.
What interventions are being tested in trial NCT05247788?
The interventions under investigation include: Blood alcohol concentration (BAC) discrimination training (BEHAVIORAL), Performance feedback training (BEHAVIORAL), Blood alcohol concentration (BAC) discrimination training for controls (BEHAVIORAL).
Who is sponsoring clinical trial NCT05247788?
This trial is sponsored by Mark Fillmore, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05247788 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05247788's enrollment target sits among peer trials
112 14th of 23 higher than 10 of 23 other Alcohol Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multi-Component Breath Alcohol Intervention Phase 3
RECRUITING · NA
-
Wellness, Alcohol, Vitals, and Emotions
RECRUITING · NA
-
Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
RECRUITING · NA
-
Stress and Resilience
RECRUITING · NA
-
The Less is More Study
RECRUITING · NA
-
Examining the Relationship Between Ongoing Alcohol Use, Suicidal Thoughts and Behaviors and Related Constructs, and Behavioral Economic Decision-Making
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI